In the context of Saudi Arabia, a Class C medical device is categorized under the Saudi Food and Drug Authority (SFDA) classification system, which is largely aligned with the IMDRF/GHTF framework.
A Class C medical device is considered moderate-to-high risk. These devices:
Usually support or sustain life
Pose a moderate risk if malfunctioning
Often are used in serious diagnostic or therapeutic procedures
Examples:
Infusion pumps
Diagnostic X-ray equipment
Wound dressings with antimicrobial agents
Bone fixation plates
Saudi Arabia regulates medical devices through the SFDA’s Medical Devices Interim Regulation, which includes:
Establishment Licensing
Medical Device Marketing Authorization (MDMA)
Post-market obligations
Registering a Class C medical device means:
Proving its safety and effectiveness
Demonstrating manufacturing quality (ISO 13485)
Complying with local (SFDA) and international (IMDRF) regulatory standards
Obtaining marketing authorization (MDMA license) to legally sell in the KSA market
If you are not based in Saudi Arabia, you must appoint a local AR:
The AR acts as a regulatory liaison with SFDA
Handles application submissions, vigilance, recalls
Must hold a valid Establishment License (EL) from SFDA
Both the manufacturer and distributor/importer/AR must be registered in SFDA’s GHAD system.
Document requirements for Establishment Licensing (EL):
Valid commercial registration
Quality management system certification (e.g., ISO 13485)
Authorized person details
AR contract or agreement
Use SFDA’s Risk Classification Rules, based on IMDRF/GHTF guidance.
You may optionally request a classification consultation from SFDA to confirm your product is Class C.
Submit through the SFDA MDMA Portal with the following documentation:
| Document | Notes |
|---|---|
| Technical File | According to GHTF/IMDRF format |
| ISO 13485 Certificate | For QMS validation |
| Free Sale Certificate (FSC) | From country of origin |
| Clinical Evaluation Report (CER) | Class C requires evidence of clinical safety/performance |
| Risk Management File | As per ISO 14971 |
| Device labeling + Instructions for Use (Arabic & English) | Regulatory requirement |
| Declaration of Conformity | Manufacturer declaration |
| Product Brochure / Catalog | Helps reviewers identify device |
| GMDN/IMDRF code | Device identification |
| Post-Market Surveillance Plan | Required for Class C devices |
Use the MDMA e-service within SFDA’s GHAD system.
Pay the application fee (~8,000–15,000 SAR depending on device complexity).
SFDA will assess:
Device classification
Conformity with safety and performance requirements
Labeling compliance
Manufacturing and clinical evidence
⏱ Typical Review Time: 3–6 months
Once approved:
You’ll receive a Medical Device Marketing Authorization Certificate
This allows legal sale and distribution of the device in Saudi Arabia
🕒 Validity: Usually 3 years
Vigilance reporting (adverse events, recalls)
PMS activities
Renewal of MDMA before expiration
Ongoing Arabic labeling compliance
Possible local inspection or audit
| Step | Description | Responsible Party |
|---|---|---|
| 1 | Appoint AR | Manufacturer |
| 2 | Establishment License (EL) | AR & Manufacturer |
| 3 | Device Classification | AR or Manufacturer |
| 4 | Technical Documentation Preparation | Manufacturer |
| 5 | MDMA Application Submission | AR |
| 6 | SFDA Review | SFDA |
| 7 | MDMA Approval | SFDA |
| 8 | Post-Market Surveillance | AR & Manufacturer |

Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn